6
MERK0203.TXT

MERK
Merck Indonesia Tbk
Af          :
Sector Code : 53
Sector Name : PHARMACEUTICALS

(In thousand rupiah except Par Value, Closing Price and Ratios)

Financial Statement Date    : 31-Mar-2002
Fiscal Year Ends            : Dec
Months Covered in Income St : 3

Summary of Balance Sheet
  Receivables               :      67,302,708.00
  Inventories               :      40,907,645.00
  Current Assets            :     138,370,085.00
  Fixed Assets              :      14,310,975.00
  Other Asstes              :       6,440,175.00
  Total Assets              :     169,642,895.00
  Current Liabilities       :      25,709,584.00
  Longterm Liabiities       :               0.00
  Total Liabilities         :      25,709,584.00
  Authorized                :          22,400.00
  Paid-up Capital           :      22,400,000.00
  Par Value                 :               1000
  Paid-up Capital Shares    :          22,400.00
  Retained Earnings         :     102,669,059.00
  Total Equity              :     143,933,311.00
  Minority Interest         :               0.00

Summary of Income Statement
  Total Sales               :      62,640,456.00
  Cost of Good Sold         :      24,875,816.00
  Gross Profit              :      37,764,640.00
  Operating Profit          :      22,561,965.00
  Other Income              :         922,752.00
  Eearning Before Tax       :      23,484,717.00
  Tax                       :       7,045,415.00
  Net Income                :      16,439,302.00
  Closing Price             :          12,300.00

Per Share Data (Rp)
  Eps                       :           2,935.59
  Book Value                :           6,425.59

Financial Ratios
  Debt Equity Ratio (X)     :                .18
  Roa (%)                   :              38.76
  Roe (%)                   :              45.69
  Npm (%)                   :              26.24
  Opm (%)                   :              36.02

Cash Flow
  CF from Operating Activities                        :      -9,679,285.00
  CF from Investing Activities                        :        -467,391.00
  CF from Financing Activities                        :               0.00
  Net Increase in Cash & Cash Equivalent              :     -10,146,676.00
  Cash & Cash Equivalent at The Beginning of The Year :      34,013,078.00
  Cash & Cash Equivalent at The End of The Year       :      23,866,402.00

 
 
 
